| # | Drug | Count |
|---|---|---|
| 0 | TEPROTUMUMAB | 30 |
| 1 | OMEPRAZOLE MAGNESIUM | 12 |
| 2 | OMEPRAZOLE | 10 |
| 3 | BISOPROLOL FUMARATE | 7 |
| 4 | BUPRENORPHINE | 7 |
| 5 | CLOPIDOGREL | 7 |
| 6 | CLOPIDOGREL BISULFATE | 7 |
| 7 | MELOXICAM | 7 |
| 8 | ALEMTUZUMAB | 6 |
| 9 | CYCLOSPORINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEPROTUMUMAB | 30 | 0.0050 |
| 1 | BETAXOLOL | 1 | 0.0012 |
| 2 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 3 | OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC | 2 | 0.0008 |
| 4 | NEOMYCIN OINTMENT | 2 | 0.0008 |
| 5 | POLYVINYL ALCOHOL, POVIDONE | 2 | 0.0008 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM | 1 | 0.0005 |
| 7 | SELENIUM | 2 | 0.0005 |
| 8 | PERFLUOROHEXYLOCTANE | 1 | 0.0004 |
| 9 | ARTIFICIAL TEARS | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 30 | 0.0050 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 6 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Partial Opioid Agonist [EPC] | 7 | 0.0001 |
| 9 | Androgen [EPC] | 2 | 0.0001 |